Respiratory Syncytial Virus: Current Progress in Vaccine Development
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Respiratory Syncytial Virus: Current Progress in Vaccine Development
Authors
Keywords
-
Journal
Viruses-Basel
Volume 5, Issue 2, Pages 577-594
Publisher
MDPI AG
Online
2013-02-06
DOI
10.3390/v5020577
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Challenges in developing a pediatric RSV vaccine
- (2014) Jeanne H. Schickli et al. Human vaccines & immunotherapeutics
- Reduced Frequencies and Heightened CD103 Expression among Virus-Induced CD8+T Cells in the Respiratory Tract Airways of Vitamin A-Deficient Mice
- (2012) Rajeev Rudraraju et al. Clinical and Vaccine Immunology
- Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008
- (2012) Hong Zhou et al. CLINICAL INFECTIOUS DISEASES
- Respiratory Syncytial Virus Modified by Deletions of the NS2 Gene and Amino Acid S1313 of the L Polymerase Protein Is a Temperature-Sensitive, Live-Attenuated Vaccine Candidate That Is Phenotypically Stable at Physiological Temperature
- (2012) C. Luongo et al. JOURNAL OF VIROLOGY
- Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice
- (2012) Tobias Kamphuis et al. PLoS One
- Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats
- (2012) Gale Smith et al. PLoS One
- Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles
- (2012) S. Garlapati et al. VACCINE
- Vitamin A Deficiency Disrupts Vaccine-Induced Antibody-Forming Cells and the Balance of IgA/IgG Isotypes in the Upper and Lower Respiratory Tract
- (2012) Sherri L. Surman et al. VIRAL IMMUNOLOGY
- Nonclinical phenotypic and genotypic analyses of a Phase 1 pediatric respiratory syncytial virus vaccine candidate MEDI-559 (rA2cp248/404/1030ΔSH) at permissive and non-permissive temperatures
- (2012) Jeanne H. Schickli et al. VIRUS RESEARCH
- Follicular Helper CD4 T Cells (TFH)
- (2011) Shane Crotty Annual Review of Immunology
- The many faces of Th17 cells
- (2011) Anneli Peters et al. CURRENT OPINION IN IMMUNOLOGY
- Respiratory syncytial virus vaccine development
- (2011) Julia L Hurwitz Expert Review of Vaccines
- Design and Characterization of Epitope-Scaffold Immunogens That Present the Motavizumab Epitope from Respiratory Syncytial Virus
- (2011) Jason S. McLellan et al. JOURNAL OF MOLECULAR BIOLOGY
- Eosinophils are required for the maintenance of plasma cells in the bone marrow
- (2011) Van Trung Chu et al. NATURE IMMUNOLOGY
- Identification of nucleolin as a cellular receptor for human respiratory syncytial virus
- (2011) Farnoosh Tayyari et al. NATURE MEDICINE
- Phase 1 Study of the Safety and Immunogenicity of a Live, Attenuated Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Vaccine in Seronegative Children
- (2011) David I. Bernstein et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers
- (2011) K. A. Swanson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands
- (2011) Muhammad Shafique et al. VACCINE
- Sendai virus-based RSV vaccine protects African green monkeys from RSV infection
- (2011) Bart G. Jones et al. VACCINE
- Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years
- (2011) Peter L. Collins et al. VIRUS RESEARCH
- A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season
- (2010) Pilar Fernández et al. BMC Pediatrics
- New insights for development of a safe and protective RSV vaccine
- (2010) Jorge C. G. Blanco et al. Human vaccines & immunotherapeutics
- Smallpox vaccines: targets of protective immunity
- (2010) Bernard Moss IMMUNOLOGICAL REVIEWS
- Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
- (2010) Barney S. Graham IMMUNOLOGICAL REVIEWS
- Efficient Lung Recruitment of Respiratory Syncytial Virus-Specific Th1 Cells Induced by Recombinant Bacillus Calmette-Guerin Promotes Virus Clearance and Protects from Infection
- (2010) K. M. Cautivo et al. JOURNAL OF IMMUNOLOGY
- Transgenic apple expressing an antigenic protein of the human respiratory syncytial virus
- (2010) Joann M. Lau et al. JOURNAL OF PLANT PHYSIOLOGY
- Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins
- (2010) L. W. McGinnes et al. JOURNAL OF VIROLOGY
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
- (2010) Harish Nair et al. LANCET
- A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
- (2010) J. DeVincenzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation
- (2010) Toon Stegmann et al. VACCINE
- AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats
- (2010) Akihito Sawada et al. VACCINE
- Respiratory viruses and eosinophils: Exploring the connections
- (2009) Helene F. Rosenberg et al. ANTIVIRAL RESEARCH
- Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus
- (2009) R. Kohlmann et al. JOURNAL OF VIROLOGY
- Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology
- (2009) M. R. Murawski et al. JOURNAL OF VIROLOGY
- Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice
- (2009) W. Zhang et al. JOURNAL OF VIROLOGY
- Antibody affinity maturation and respiratory syncytial virus disease
- (2009) Christine A Shaw et al. NATURE MEDICINE
- Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV
- (2009) Bart Jones et al. VACCINE
- Pulmonary Eosinophilia Is Attenuated by Early Responding CD8+ Memory T Cells in a Murine Model of RSV Vaccine-Enhanced Disease
- (2009) Whitney W. Stevens et al. VIRAL IMMUNOLOGY
- Target Peptide Sequence within Infectious Human Immunodeficiency Virus Type 1 Does Not Ensure Envelope-Specific T-Helper Cell Reactivation: Influences of Cysteine Protease and Gamma Interferon-Induced Thiol Reductase Activities
- (2008) R. Sealy et al. Clinical and Vaccine Immunology
- Young Infants Can Develop Protective Levels of Neutralizing Antibody after Infection with Respiratory Syncytial Virus
- (2008) Joshua J. Shinoff et al. JOURNAL OF INFECTIOUS DISEASES
- Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
- (2008) Maria Florencia Delgado et al. NATURE MEDICINE
- Risk Factors for Severe Respiratory Syncytial Virus Disease in Children With Cancer: The Importance of Lymphopenia and Young Age
- (2008) C. M. El Saleeby et al. PEDIATRICS
- Development of a PIV-vectored RSV vaccine: Preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults
- (2008) Roderick S. Tang et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started